Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
Manish B Jhawar, Greg FlakerUniversity of Missouri, Division of Cardiovascular Medicine, Columbia, Missouri, USAAbstract: Atrial fibrillation is the most common of the cardiac arrhythmias and is associated with high risk of stroke and systemic thromboembolism. Prevention of these complications is th...
Main Authors: | Jhawar MB, Flaker G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-04-01
|
Series: | Journal of Blood Medicine |
Online Access: | http://www.dovepress.com/preventing-stroke-in-atrial-fibrillation-patients-ndash-clinical-utili-a9686 |
Similar Items
-
Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations
by: Ahrens I, et al.
Published: (2014-02-01) -
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
by: Tommaso Sacquegna, et al.
Published: (2015-12-01) -
Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation
by: Caroline Brais, et al.
Published: (2017-01-01) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01) -
Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
by: Luger S, et al.
Published: (2015-11-01)